-Yasuro Furuichi Researcher Activity Profile

Research Author Detailed Information 

Yasuro Furuichi Publication Rate By Year

Yasuro Furuichi has published 1 paper(s) in 1969, 2 paper(s) in 1992, 1 paper(s) in 1996, 1 paper(s) in 2001, 1 paper(s) in 2005, 1 paper(s) in 2006, 5 paper(s) in 2007, 5 paper(s) in 2008, for a total of 17 research publications in total.

Yasuro Y Furuichi Author Information

LAST NAME: furuichi

FIRST NAME: Yasuro

INITIALS: y

AFFILIATION:

Papers

Yasuro Furuichi's Publication Record

1. Effect of Intensive Interval Training During Unloading on the Muscle Oxygenation Kinetics: 1905: Board #193 10:30 AM - 10:30 AM. Year Published: 2007
1Kanazawa University, Kanazawa, Japan. 2Nagoya University, Nagoya, Japan. 3National Institute of Health and Nutrition, Tokyo, Japan.
2. Fms-like tyrosine kinase 3 ligand stimulation induces MLL-rearranged leukemia cells into quiescence resistant to antileukemic agents. Year Published: 2007
Department of Pediatrics, School of Medicine, University of Yamanashi, Yamanashi, Japan.
3. The carboxyl terminal sequence of nucleolar protein B23.1 is important in its DNA polymerase alpha-stimulatory activity. Year Published: 2001
Department of Sustainable Resource Science, Faculty of Bioresources, Mie University, Tsu, Mie 514-8507, Japan. umekawa@bio.mie-u.ac.jp
4. Ribonuclease T1-catalyzed synthesis of triribonucleoside diphosphates having guanosine residue at the 5'-end. Year Published: 1969
5. Different stability of ligand-receptor complex formed with two endothelin receptor species, ETA and ETB. Year Published: 1992
Department of Molecular Genetics, Nippon Roche Research Center, Kanagawa.
6. Characterization of endothelin receptors ETA and ETB expressed in COS cells. Year Published: 1992
Department of Molecular Genetics, Nippon Roche Research Center, Kanagawa.
7. Pore formation on proliferating yeast Saccharomyces cerevisiae cell buds by HM-1 killer toxin. Year Published: 1996
Department of Biochemistry, Niigata College of Pharmacy. komiyam@niigata-pharm.ac.jp
8. Alanine-scanning mutagenesis of HM-1 killer toxin and the essential residues for killing activity. Year Published: 2005
Department of Biochemistry, Faculty of Pharmaceutical Sciences, Niigata University of Pharmacy and Applied Life Sciences, 5-13-2 Kamishinei-cho, Niigata 950-2081. miyamoto@niigata-pharm.ac.jp
9. Identification and characterization of a neutralizing monoclonal antibody for the epitope on HM-1 killer toxin. Year Published: 2006
Department of Biochemistry, Faculty of Pharmaceutical Sciences, Niigata University of Pharmacy and Applied Life Sciences, 5-13-2 Kamishinei-cho, Niigata 950-208.
10. Fms-like tyrosine kinase 3 ligand stimulation induces MLL-rearranged leukemia cells into quiescence resistant to antileukemic agents. Year Published: 2007
Department of Pediatrics, School of Medicine, University of Yamanashi, Yamanashi, Japan.
11. Induction of mitotic cell death in cancer cells by small interference RNA suppressing the expression of RecQL1 helicase. Year Published: 2007
GeneCare Research Institute, 19-2 Kajiwara, Kamakura, Kanagawa 247-0063, Japan.
12. Comparison of injectable calcium phosphate bone cement grafting and open flap debridement in periodontal intrabony defects: a randomized clinical trial. Year Published: 2008
Department of Periodontology, Kagoshima University Graduate School of Medical and Dental Sciences, Kagoshima, Japan. syoshi@denta.hal.kagoshima-u.ac.jp
13. A case of splenic inflammatory pseudotumor. Year Published: 2008
Department of Gastroenterology and Hepatology, Tokyo Medical University.
14. Induction of mitotic cell death in cancer cells by small interference RNA suppressing the expression of RecQL1 helicase. Year Published: 2007
GeneCare Research Institute, 19-2 Kajiwara, Kamakura, Kanagawa 247-0063, Japan.
15. A novel small-molecule inhibitor of NF-kappaB signaling. Year Published: 2008
Department of Drug Discovery Research, GENECARE Research Institute, 19-2 Kajiwara, Kamakura, Kanagawa 247-0063, Japan.
16. Role of Werner syndrome gene product helicase in carcinogenesis and in resistance to genotoxins by cancer cells. Year Published: 2008
GeneCare Research Institute, TECOM 2nd Building, 19-2 Kajiwara, Kamakura, Kanagawa 247-0063, Japan.
17. Role of Werner syndrome gene product helicase in carcinogenesis and in resistance to genotoxins by cancer cells. Year Published: 2008
GeneCare Research Institute, TECOM 2nd Building, 19-2 Kajiwara, Kamakura, Kanagawa 247-0063, Japan.